Rafferty Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-236,732
Closed -$1.05M 1110
2024
Q4
$1.05M Sell
236,732
-159,932
-40% -$708K ﹤0.01% 783
2024
Q3
$1.63M Buy
396,664
+12,312
+3% +$50.7K 0.01% 686
2024
Q2
$2.51M Sell
384,352
-633,467
-62% -$4.13M 0.01% 583
2024
Q1
$8.87M Buy
1,017,819
+316,049
+45% +$2.75M 0.03% 312
2023
Q4
$8.03M Sell
701,770
-172,282
-20% -$1.97M 0.03% 336
2023
Q3
$8.42M Buy
874,052
+148,881
+21% +$1.43M 0.05% 269
2023
Q2
$7.72M Buy
725,171
+102,996
+17% +$1.1M 0.04% 298
2023
Q1
$6.55M Sell
622,175
-58,837
-9% -$619K 0.04% 313
2022
Q4
$8.44M Buy
681,012
+51,038
+8% +$632K 0.07% 238
2022
Q3
$6.53M Buy
629,974
+304,990
+94% +$3.16M 0.07% 247
2022
Q2
$3.75M Sell
324,984
-133,208
-29% -$1.54M 0.03% 344
2022
Q1
$5.76M Sell
458,192
-18,594
-4% -$234K 0.03% 348
2021
Q4
$5.56M Buy
476,786
+221,371
+87% +$2.58M 0.03% 348
2021
Q3
$3.34M Buy
255,415
+33,038
+15% +$432K 0.02% 419
2021
Q2
$2.86M Sell
222,377
-72,073
-24% -$928K 0.02% 518
2021
Q1
$3.29M Buy
294,450
+228,223
+345% +$2.55M 0.02% 427
2020
Q4
$754K Sell
66,227
-128,435
-66% -$1.46M 0.01% 588
2020
Q3
$1.75M Buy
194,662
+106,277
+120% +$956K 0.02% 455
2020
Q2
$912K Buy
88,385
+72,324
+450% +$746K 0.01% 572
2020
Q1
$162K Sell
16,061
-147,926
-90% -$1.49M 0.01% 540
2019
Q4
$2.18M Sell
163,987
-102,699
-39% -$1.37M 0.03% 357
2019
Q3
$2.29M Buy
266,686
+9,440
+4% +$81K 0.04% 315
2019
Q2
$2.81M Buy
257,246
+12,568
+5% +$137K 0.05% 269
2019
Q1
$2.77M Buy
+244,678
New +$2.77M 0.04% 248